These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9647767)

  • 1. Trimidox-mediated morphological changes during erythroid differentiation is associated with the stimulation of hemoglobin and F-cell production in human K562 cells.
    Iyamu EW; Adunyah SE; Elford HL; Fasold H; Turner EA
    Biochem Biophys Res Commun; 1998 Jun; 247(3):759-64. PubMed ID: 9647767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin.
    Iyamu WE; Adunyah SE; Fasold H; Horiuchi K; Elford HL; Asakura T; Turner EA
    Am J Hematol; 2000 Apr; 63(4):176-83. PubMed ID: 10706760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity.
    Mayhew CN; Phillips JD; Greenberg RN; Birch NJ; Elford HL; Gallicchio VS
    Stem Cells; 1999; 17(6):345-56. PubMed ID: 10606163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The ribonucleotide reductase enzyme as a target for enzyme-directed chemotherapy effects of trimidox (3,4,5-trihydroxybenzohydroxamidoxim), a new inhibitor of ribonucleotide reductases].
    Findenig G; Vielnascher E; Göbl R; Fritzer-Szekeres M; Szekeres T
    Wien Klin Wochenschr; 1995; 107(22):694-7. PubMed ID: 8533431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibitory and differentiation effects of chloroquine and its analogue on human leukemic cells potentiate fetal hemoglobin production by targeting the polyamine pathway.
    Iyamu E; Perdew H; Woods G
    Biochem Pharmacol; 2009 Mar; 77(6):1021-8. PubMed ID: 19073155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells.
    Leyden D; Ahmed N; Hassan HT
    Anticancer Res; 2000; 20(1A):133-8. PubMed ID: 10769645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin-mediated induction of gamma-globin mRNA accumulation in human erythroid cells.
    Mischiati C; Sereni A; Lampronti I; Bianchi N; Borgatti M; Prus E; Fibach E; Gambari R
    Br J Haematol; 2004 Aug; 126(4):612-21. PubMed ID: 15287957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL; Wu RT
    Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
    Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
    Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation.
    Rodrigue CM; Arous N; Bachir D; Smith-Ravin J; Romeo PH; Galacteros F; Garel MC
    Br J Haematol; 2001 May; 113(2):500-7. PubMed ID: 11380423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase.
    Szekeres T; Gharehbaghi K; Fritzer M; Woody M; Srivastava A; van't Riet B; Jayaram HN; Elford HL
    Cancer Chemother Pharmacol; 1994; 34(1):63-6. PubMed ID: 8174204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response.
    Okafuji K; Kaku K; Seguchi M; Tanaka H; Azuno Y; Kaneko T
    Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanadate elevates fetal hemoglobin in human erythroid precursors by inhibiting cell maturation.
    Amoyal I; Prus E; Fibach E
    Exp Biol Med (Maywood); 2007 May; 232(5):654-61. PubMed ID: 17463162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on erythroid differentiation of platinum(II) complexes of synthetic bile acid derivatives.
    Lampronti I; Bianchi N; Zuccato C; Medici A; Bergamini P; Gambari R
    Bioorg Med Chem; 2006 Aug; 14(15):5204-10. PubMed ID: 16709458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cells.
    Szekeres T; Fritzer M; Strobl H; Gharehbaghi K; Findenig G; Elford HL; Lhotka C; Schoen HJ; Jayaram HN
    Blood; 1994 Dec; 84(12):4316-21. PubMed ID: 7994048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative effects of hemin and anthracyclines in promoting terminal erythroid maturation in K562 human erythroleukemia cells.
    Tsiftsoglou AS; Wong W; Tsamadou AI; Robinson SH
    Exp Hematol; 1991 Oct; 19(9):928-33. PubMed ID: 1893971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ERK activation in growth and erythroid differentiation of K562 cells.
    Woessmann W; Mivechi NF
    Exp Cell Res; 2001 Apr; 264(2):193-200. PubMed ID: 11262176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.
    Fritzer-Szekeres M; Salamon A; Grusch M; Horvath Z; Höchtl T; Steinbrugger R; Jäger W; Krupitza G; Elford HL; Szekeres T
    Biochem Pharmacol; 2002 Aug; 64(3):481-5. PubMed ID: 12147300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ribonucleotide reductase inhibitor trimidox induces c-myc and apoptosis of human ovarian carcinoma cells.
    Rosenberger G; Fuhrmann G; Grusch M; Fassl S; Elford HL; Smid K; Peters GJ; Szekeres T; Krupitza G
    Life Sci; 2000 Nov; 67(26):3131-42. PubMed ID: 11191620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of nonmyelosuppressive nitrosourea analogues with hydroxyurea in the induction of F-cell production in a human erythroleukemic cell line.
    Iyamu EW; Adunyah SE; Fasold H; Horiuchi K; Baliga S; Ohene-Frempong K; Turner EA; Asakura T
    Exp Hematol; 2003 Jul; 31(7):592-600. PubMed ID: 12842704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.